Heart Failure, Cardiomyopathy, Preventive Cardiology, and Quality of Care/Outcomes.
Dr. Gregg C. Fonarow serves as Director of the Ahmanson-UCLA Cardiomyopathy Center, Co-Chief of UCLA's Division of Cardiology, and Co-director of UCLA's Preventative Cardiology Program. He attained the rank of Professor of Medicine in 2003. He was awarded the Eliot Corday Chair in Cardiovascular Medicine and Science in 2003. His research interests center on heart failure management, preventative cardiology, disease management, and implementing treatment systems to improve clinical outcome. Dr Fonarow has published over 400 research studies and clinical trials in heart failure management, preventative cardiology, and outcomes research. New therapies and management strategies for advanced heart failure and research into the pathophysiology of this disease are conducted at UCLA under his direction. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiovascular Hospitalization Atherosclerosis Management Program: CHAMP). Dr Fonarow is on the steering committee for the American Heart Association's Get with the Guidelines (GWTG) program, ADHERE Registries, and OPTIMIZE-HF. He serves as a reviewer and on the editorial boards of a number of leading cardiovascular journals. Dr. Fonarow received the outstanding UCLA Cardiology Faculty Teaching Award in 1997 and was honored by the American College of Cardiology with the W. Proctor Harvey Young Teacher Award in 1998. He received a AHA Award of Meritorious Achievement in 2004.